| 分子名 |
货号 |
物种 |
表达系统 |
产品描述 |
蛋白结构 |
纯度 |
特性 |
包装/价格 |
| HLA-A*0201 & B2M & NY-ESO-1 (SLLMWITQV)
|
HL1-HA2H8
|
 Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein
|
|
|
|
|
| HLA-A*3001 & B2M & KRASG12V (VVGAVGVGK)
|
HLV-HA2H7
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*30:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein
|
|
|
|
|
| H-2Db & B2M & TRP1 (TAPDNLGYA)
|
H2P-HA2H7
|
 Mouse
|
HEK293
|
APC-Labeled Mouse H-2Db&B2M&TRP1 (TAPDNLGYA) Tetramer Protein
|
|
|
|
|
| HLA-E*0103 & B2M & EBV BZLF-1 (SQAPLPCVL)
|
HLF-HA2H7
|
Human
|
HEK293
|
APC-Labeled Human HLA-E*01:03&B2M&EBV BZLF-1 (SQAPLPCVL) Tetramer Protein
|
|
|
|
|
| HLA-E*0103 & B2M & EBV LMP1 (GGDPHLPTL)
|
HLP-HA2H8
|
Human
|
HEK293
|
APC-Labeled Human HLA-E*01:03&B2M&EBV LMP1 (GGDPHLPTL) Tetramer Protein
|
|
|
|
|
| HLA-A*0201 & B2M & hTERT (ILAKFLHWL)
|
HLT-HA2H7
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&hTERT (ILAKFLHWL) Tetramer Protein
|
|
|
|
|
| HLA-A*0201 & B2M & WT-1 (RMFPNAPYL)
|
HLW-HA2H6
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Tetramer Protein
|
|
|
|
|
| HLA-A*0201 & B2M & MAGE-A2 (YLQLVFGIEV)
|
HLM-HA2H5
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&MAGE-A2 (YLQLVFGIEV) Tetramer Protein
|
|
|
|
|
| HLA-A*0201 & B2M & MAGE-A2 (KMVELVHFL)
|
HLM-HA2H3
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&MAGE-A2 (KMVELVHFL) Tetramer Protein
|
|
|
|
|
| HLA-A*0201 & B2M & NY-ESO-1 (SLLMWITQCFL)
|
HL1-HA2H4
|
Human
|
HEK293
|
APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQCFL) Tetramer Protein
|
|
|
|
|
Star Ribbon预染蛋白Marker蛋白质标记物是生物研究和药物开发的重要组成部分。无论是用于蛋白质电泳还是western blot，我们的预染色蛋白质标记物帮助您快速确定目标蛋白质的分子量或评估转移效率。Fc受体蛋白治疗性抗体的功效取决于Fab片段及其对目标抗原的结合活性，还取决于Fc片段及其与关键Fc受体的相互作用。因此，在抗体工程中候选物必须针对一系列受体进行测试。探索我们的重组Fc受体蛋白质的全面收藏！
膜杰作
Star Staining
